PELLUCID MARGINAL DEGENERATION
Clinical trials for PELLUCID MARGINAL DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new PELLUCID MARGINAL DEGENERATION trials appear
Sign up with your email to follow new studies for PELLUCID MARGINAL DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for down syndrome vision loss: light therapy trial launches
Disease control Recruiting nowThis Phase 3 trial tests a treatment called corneal crosslinking (CXL) for people with Down syndrome who have keratoconus, a condition where the cornea thins and bulges, blurring vision. The procedure uses vitamin B2 eye drops and ultraviolet light to strengthen the cornea. Resea…
Matched conditions: PELLUCID MARGINAL DEGENERATION
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New eye scanner could sharpen diagnosis of corneal problems
Diagnosis Recruiting nowThis study aims to improve how doctors detect, classify, and treat irregular corneas caused by conditions like keratoconus, dry eye, and corneal scars. Researchers will use a special imaging device called optical coherence tomography (OCT) to get detailed measurements of the corn…
Matched conditions: PELLUCID MARGINAL DEGENERATION
Sponsor: Oregon Health and Science University • Aim: Diagnosis
Last updated Jun 26, 2026 14:49 UTC